ePrescribing Market by Offrings, Delivery Mode, End User

List of Tables

[190 Pages Report] The ePrescribing Market size was estimated at USD 147.53 million in 2023 and expected to reach USD 159.21 million in 2024, at a CAGR 8.05% to reach USD 253.79 million by 2030.

E-prescribing refers to the process of healthcare professionals generating and sending prescription orders directly to a pharmacy or healthcare facility through digital platforms. This sophisticated methodology transcends traditional paper-based prescriptions, significantly streamlining the prescribing process. It encompasses the utilization of electronic devices, such as computers and smartphones, allowing for increased accuracy, enhanced patient safety, and improved efficiency in prescription fulfillment. E-prescribing systems are integrated with patient medical records, thereby enabling prescribers to access comprehensive patient medication histories, contraindications, and allergies, ensuring optimal medication management and decision-making. Government initiatives and incentives for adopting healthcare IT solutions are increasing the applications of e-prescribing. Demand for reduced prescribing errors and improved healthcare delivery further boosted the demand for the market. However, significant investment required for setup, maintenance, and training may impede market growth. Nevertheless, integration with Electronic Health Record (EHR) systems and advanced analytics and decision support tools for personalized medication management may provide an opportunistic view for market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 147.53 million
Estimated Year [2024]	USD 159.21 million
Forecast Year [2030]	USD 253.79 million
CAGR (%)	8.05%

Regional Insights

In the Americas, ePrescribing has experienced rapid adoption due to supportive regulatory frameworks and initiatives aimed at improving healthcare efficiency and patient safety. In the U.S., the Health Information Technology for Economic & Clinical Health Act and the Medicare Prescription Drug Improvement and Modernization Act have significantly propelled the use of ePrescribing systems. Canada and Brazil are also observing substantial growth in ePrescribing adoption, driven by government policies promoting digital health infrastructure and initiatives to curb prescription errors. The region is characterized by a competitive market environment with numerous providers offering a variety of solutions that integrate with electronic health record systems. The EMEA region presents a diverse picture of ePrescribing adoption, with Europe leading in implementation. The European Union's directives aimed at the adoption of cross-border eHealth services, including ePrescriptions, have encouraged member states to accelerate digital health initiatives. The Asia Pacific region is witnessing fast-paced growth in the ePrescribing market, spurred by its large population, growing middle class, and increasing emphasis on healthcare IT initiatives. Countries including Australia, Singapore, and Japan are leading in ePrescribing adoption, supported by strong digital health infrastructures and government incentives. India and China are emerging markets with significant potential, driven by initiatives to improve healthcare access and the digitization of healthcare systems.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the ePrescribing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Government initiatives and regulations promoting the use of e-prescribing systems
- Increasing adoption of electronic health records (EHRs)
- Emerging demand for improved healthcare quality and patient safety

Market Restraints
- High initial setup and maintenance costs

Market Opportunities
- Rising investments to expand in emerging regions, and advancements in decision support systems
- Integration with telemedicine, leveraging analytics for personalized medicine

Market Challenges
- Concerns about data privacy and security

Market Segmentation Analysis
- Component: Suitability of integrated solutions for broader healthcare IT system
- Deployment: Inclination towards on-cloud deployment owing to real time data sharing and updates

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the ePrescribing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the ePrescribing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Rhyl to Launch New Electronic Prescription System for Patients

Rhyl became the inaugural location in Wales to launch an electronic prescription system, marking a significant transformation in patient care efficiency and security. This development, a first of its kind in the country, is strategically implemented to streamline the prescription process, ensuring that patients receive their medications more swiftly and safely than ever before. The deployment of this digital solution is anticipated to set a precedent, potentially revolutionizing the healthcare landscape across Wales by enhancing accessibility and reducing the margin for error in prescription handling. [Published On: 2023-11-17]

DrFirst Healthcare Innovations Collaborates with MEDITECH to Power E-Prescribing in Canada

DrFirst Healthcare Innovations announce its partnership with MEDITECH, a notable step forward in enabling electronic prescribing capabilities for hospitals utilizing the Expanse EHR system in Canada. This strategic partnership is set to enhance MEDITECH's integration with Canada Health Infoway's national e-prescribing service, PrescribeIT. The transition to e-prescribing presents a significant advancement, offering myriad benefits such as eliminating the need for faxing or telephonic prescriptions, minimizing transcription inaccuracies, curtailing potential fraud, and notably decreasing patient waiting times by removing the necessity to submit prescriptions at pharmacies physically. [Published On: 2023-08-09]

BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America

BoomerangFX, a global provider of cloud-based SaaS solutions for the private-pay healthcare sector, including specialized areas such as dermatology, cosmetic surgery, medical spas, cosmetic dentistry, vision care, and women's health, established a strategic partnership with health tech innovator DrFirst. This partnership aims to deliver a comprehensive medication management platform that enhances clinical workflows and patient engagement. This partnership is set to streamline processes and improve outcomes for healthcare providers and their patients by leveraging the strengths of both organizations in technology and healthcare solutions. [Published On: 2023-06-07]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the ePrescribing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the ePrescribing Market, highlighting leading vendors and their innovative profiles. These include 75health, Allscripts Healthcare Solutions Inc., athenahealth, Inc., Dosespot by PRN Software, LLC, DrChrono, DrFirst Inc., eazyScripts Technology, LLC, eClinicalWorks, eMDs, Inc. by CompuGroup Medical, Epocrates Inc., Healthie Inc., iCoreConnect, Intelligent Medical Software, Kareo, Inc. by Tebra Technologies, Inc., MDToolbox, MedicalMine Inc., Networking Technology, Inc., NextGen Healthcare, Inc., Optum, Inc., Oracle Corporation, Pabau, Provet Cloud, Qualifacts Systems, LLC, Surescripts, LLC, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the ePrescribing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Offrings
- Services
  - Implementation
  - Network

Solution
- Integrated,
- Standalone

Delivery Mode
- On premise
- Web & Cloud based

End User
- Hospitals
- Pharmacies
- Physician Offices

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-351BAD5037B5

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Government initiatives and regulations promoting the use of e-prescribing systems
  - 5.1.1.2. Increasing adoption of electronic health records (EHRs)
  - 5.1.1.3. Emerging demand for improved healthcare quality and patient safety
- 5.1.2. Restraints
  - 5.1.2.1. High initial setup and maintenance costs
- 5.1.3. Opportunities
  - 5.1.3.1. Rising investments to expand in emerging regions, and advancements in decision support systems
  - 5.1.3.2. Integration with telemedicine, leveraging analytics for personalized medicine
- 5.1.4. Challenges
  - 5.1.4.1. Concerns about data privacy and security
5.2. Market Segmentation Analysis
- 5.2.1. Component: Suitability of integrated solutions for broader healthcare IT system
- 5.2.2. Deployment: Inclination towards on-cloud deployment owing to real time data sharing and updates
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. ePrescribing Market, by Offrings

6.1. Introduction
6.2. Services
6.3. Solution

7. ePrescribing Market, by Delivery Mode

7.1. Introduction
7.2. On premise
7.3. Web & Cloud based

8. ePrescribing Market, by End User

8.1. Introduction
8.2. Hospitals
8.3. Pharmacies
8.4. Physician Offices

9. Americas ePrescribing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific ePrescribing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa ePrescribing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Rhyl to Launch New Electronic Prescription System for Patients
- 12.3.2. DrFirst Healthcare Innovations Collaborates with MEDITECH to Power E-Prescribing in Canada
- 12.3.3. BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio